Paula Wilcox-Pendleton
Family · Philadelphia, PANPI 1902983190
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 9.9% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 56 payments — averaging $95.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$530
- Gilead$435
- AstraZeneca$393
- AbbVie$337
- GSK$328
- Pfizer$310
- plus $3K from 23 others
What the payments were for
- Food & beverage$5,329100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 6 | $530 |
| Gilead | 4 | $435 |
| AstraZeneca | 4 | $393 |
| AbbVie | 4 | $337 |
| GSK | 3 | $328 |
| Pfizer | 3 | $310 |
| Inspire Medical Systems, Inc. | 3 | $294 |
| Johnson & Johnson | 2 | $281 |
| Phathom Pharmaceuticals, Inc. | 3 | $241 |
| Amgen(2 entities) | 2 | $222 |
| Idorsia Pharmaceuticals US Inc | 2 | $183 |
| Lilly USA, LLC | 2 | $174 |
| Sun Pharmaceutical Industries Inc. | 1 | $142 |
| Fresenius USA Marketing, Inc. | 1 | $125 |
| Sage Therapeutics, LLC | 1 | $119 |
| Heartflow, Inc. | 1 | $117 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $115 |
| Neurocrine Biosciences, Inc. | 2 | $106 |
| Esperion Therapeutics, Inc. | 1 | $106 |
| Teva Pharmaceuticals USA, Inc. | 1 | $100 |
| Cipher Pharmaceuticals US LLC | 1 | $99 |
| E.r. Squibb & Sons, L.L.C. | 1 | $88 |
| Kyowa Kirin, Inc. | 1 | $87 |
| Biogen | 1 | $77 |
| Genentech USA, Inc. | 1 | $77 |
| Insmed, Inc. | 1 | $76 |
| Regeneron Healthcare Solutions, Inc. | 1 | $76 |
| Neurelis, Inc. | 1 | $59 |
| Biohaven Pharmaceuticals, Inc. | 1 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$170
- DRIZALMA SPRINKLE$142
- AIRSUPRA$125
- Velphoro$125
- Veklury$125
- AREXVY$123
- ACTIMMUNE$120
- FFRct$117
- NURTEC ODT$115
- PREVNAR 20$114
- Inspire$113
- SPRAVATO$111
- QUVIVIQ$107
- NEXLIZET$106
- NEXLETOL$106
- TRELEGY ELLIPTA$104
- FARXIGA$103
- OXBRYTA$103
- Otezla$102
- NUCALA$101
How this compares
$5,329 in reported general payments places this provider in the 90th percentile of 4,717 family providers in Pennsylvania.
Other family in Philadelphia
- Bethany ThomasPhiladelphia$126K
- Anne CalvaresiPhiladelphia$81K
- Bethany MooneyPhiladelphia$73K
- Susan Estrella-EadesPhiladelphia$61K
- Michelle Vega-OlivoPhiladelphia$55K
- Danielle LandPhiladelphia$48K
- Nicole SmithPhiladelphia$37K
- Dana SerafinPhiladelphia$31K
- Tammaris KaschakPhiladelphia$27K
- Laura NoltePhiladelphia$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.